Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation

Abiraterone is a selective inhibitor of androgen biosynthesis approved for the treatment of metastatic patients affected by castration-resistant or castration-sensitive prostate cancer. Intriguingly, clinical data revealed that abiraterone also delayed disease progression in bone improving bone-rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Iuliani, Michele, Simonetti, Sonia, Ribelli, Giulia, Cavaliere, Silvia, Vincenzi, Bruno, Tonini, Giuseppe, Pantano, Francesco, Santini, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496251/
https://www.ncbi.nlm.nih.gov/pubmed/36140255
http://dx.doi.org/10.3390/biomedicines10092154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496251/
https://www.ncbi.nlm.nih.gov/pubmed/36140255
http://dx.doi.org/10.3390/biomedicines10092154

Ejemplares similares